These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


148 related items for PubMed ID: 824294

  • 1. Prevention of oral infections in patients receiving cancer therapy.
    Lavelle CL.
    Dent J; 1976 Nov; 42(11):551-3. PubMed ID: 824294
    [No Abstract] [Full Text] [Related]

  • 2. Oral complications in cancer patients.
    Bodey GP, Dreizen S.
    Chemioterapia; 1987 Jun; 6(2 Suppl):731-3. PubMed ID: 3509534
    [No Abstract] [Full Text] [Related]

  • 3. [Importance of prevention of infectious complications in pediatric hematologic-oncologic patients].
    Fleischhack G, Simon A.
    Klin Padiatr; 2001 Sep; 213 Suppl 1():A5-8. PubMed ID: 11577360
    [Abstract] [Full Text] [Related]

  • 4. Critical appraisal of antimicrobials for prevention of infections in immunocompromised hosts.
    Hathorn JW.
    Hematol Oncol Clin North Am; 1993 Oct; 7(5):1051-99. PubMed ID: 8226565
    [Abstract] [Full Text] [Related]

  • 5. [Prevention of infections in cancer patients with the help of antimicrobial agents].
    Syrjänen J, Kujala P, Sinisalo M, Lumio J.
    Duodecim; 2002 Oct; 118(21):2233-9. PubMed ID: 12486960
    [No Abstract] [Full Text] [Related]

  • 6. [Possibilities and limits for preventing infections in persons with a cellular immunity deficit].
    Teodorovici G.
    Rev Med Chir Soc Med Nat Iasi; 1986 Oct; 90(1):14-8. PubMed ID: 3094113
    [No Abstract] [Full Text] [Related]

  • 7. USPHS/IDSA guidelines for the prevention of opportunistic infections in persons infected with human immunodeficiency virus: disease-specific recommendations. USPHS/IDSA Prevention of Opportunistic Infections Working Group.
    Clin Infect Dis; 1995 Aug; 21 Suppl 1():S32-43. PubMed ID: 8547510
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Oral complications of childhood cancer and its treatment: current best practice.
    Belfield PM, Dwyer AA.
    Eur J Cancer; 2004 May; 40(7):1035-41; discussion 1042-4. PubMed ID: 15093579
    [No Abstract] [Full Text] [Related]

  • 10. [Bacteriologic management of patients with decreased resistance].
    Hendriks WD, Sizoo W, Löwenberg B, Hagenbeek A.
    Ned Tijdschr Geneeskd; 1984 Feb 18; 128(7):305-10. PubMed ID: 6422314
    [No Abstract] [Full Text] [Related]

  • 11. How do we manage oral infections in allogeneic stem cell transplantation and other severely immunocompromised patients?
    Palmason S, Marty FM, Treister NS.
    Oral Maxillofac Surg Clin North Am; 2011 Nov 18; 23(4):579-99, vii. PubMed ID: 21982611
    [Abstract] [Full Text] [Related]

  • 12. [Prevention of infection in recipients of solid organ transplants].
    Lumbreras C, Otero JR, Aguado JM.
    Enferm Infecc Microbiol Clin; 1997 May 18; 15 Suppl 2():77-89. PubMed ID: 9312302
    [No Abstract] [Full Text] [Related]

  • 13. The granulocytopenic patient: another consideration for antimicrobial prophylaxis.
    Otis LL, Terezhalmy GT.
    Oral Surg Oral Med Oral Pathol; 1985 Jul 18; 60(1):125-9. PubMed ID: 3162130
    [Abstract] [Full Text] [Related]

  • 14. Infections in cancer patients.
    Rodriguez V.
    Compr Ther; 1980 Oct 18; 6(10):62-7. PubMed ID: 6778650
    [No Abstract] [Full Text] [Related]

  • 15. [Prevention and therapy of infections in tumor patients].
    Burgmann H.
    Wien Med Wochenschr; 2001 Oct 18; 151(24):600-14. PubMed ID: 11820177
    [Abstract] [Full Text] [Related]

  • 16. [Prevention of infections with chemotherapeutic agents].
    Lang W.
    Munch Med Wochenschr; 1973 Aug 31; 115(35):1486-9. PubMed ID: 4740820
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Section VI. Haemodialysis-associated infection.
    European Best Practice Guidelines Expert Group on Hemodialysis, European Renal Association.
    Nephrol Dial Transplant; 2002 Aug 31; 17 Suppl 7():72-87. PubMed ID: 12386234
    [No Abstract] [Full Text] [Related]

  • 20. New guidelines are a comprehensive resource for managing infection risk among hematopoietic stem cell transplant patients.
    Rollins G.
    Rep Med Guidel Outcomes Res; 2000 Nov 30; 11(23):1-2, 5. PubMed ID: 11899981
    [No Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 8.